Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Pedro Ramirez

Neurological Surgery Lake Mary, FL Medical Doctor

NPI 1689847733 CMS profile 1320867

978 International Pkwy Ste 1440, Lake Mary, FL 32746

Open in the dashboard

General payments

$146,717

467 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Pedro Ramirez of Lake Mary, FL is reported in the CMS Open Payments database as having received $146,717 across 467 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $33,982 63
2024 General $28,002 40
2023 General $20,335 74
2022 General $15,993 81
2021 General $11,908 77
2020 General $3,404 42
2019 General $33,094 90

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Pedro Ramirez
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Pedro Ramirez were reported at $33,982. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Pedro Ramirez Neurological Surgery median Middle half National median
2019 $33,094 $582 $138–$3,006 $163
2020 $3,404 $294 $76–$2,174 $114
2021 $11,908 $387 $105–$2,432 $132
2022 $15,993 $542 $139–$2,989 $149
2023 $20,335 $534 $145–$2,697 $160
2024 $28,002 $574 $155–$3,046 $164
2025 $33,982 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. SurGenTec $58,384 8 payments
  2. Spine Wave, Inc. $36,281 44 payments
  3. SI-BONE, Inc. $12,617 59 payments
  4. Captiva Spine Inc $12,166 4 payments
  5. Augmedics Inc. $8,067 12 payments
  6. Abbott Laboratories $4,466 70 payments
  7. Alphatec Spine, Inc $4,422 13 payments
  8. Nevro Corp. $3,316 47 payments
  9. Nexxt Spine LLC $1,143 4 payments
  10. Boston Scientific Corporation $1,045 32 payments
  11. Other $4,809 174 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $64,552 33 payments
  2. Royalty or License $39,675 4 payments
  3. Travel and Lodging $24,456 49 payments
  4. Food and Beverage $12,904 373 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,031 2 payments
  6. Education $1,100 6 payments
Products named General payments · program years 2019–2025
  1. Xvision $40,334 60 payments
  2. TiLink Orthopedic $33,328 5 payments
  3. ION $22,399 3 payments
  4. TiLink Device $17,004 1 payment
  5. EXCEED BIPLANAR EXPANDABLE INTERBODY SYSTEM $14,872 9 payments
  6. IFUSE IMPLANT $12,536 57 payments
  7. CapLOX II $12,166 4 payments
  8. Spinal Implants $8,458 10 payments
  9. ION Facet Screw $8,053 2 payments
  10. ION Facet Screw System $6,428 1 payment
  11. Other $22,024 376 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 11 drugs

Part D claims

299

Median for Neurosurgery: 83

Drug cost

$2,208

Median for Neurosurgery: $872

Branded share of claims

28.8%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Baclofen Generic 52 $560
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 74 $473
Cephalexin Generic 35 $431
Methocarbamol Generic 15 $168
Gabapentin Generic 12 $117
Ciprofloxacin Hcl Generic 13 $102
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 12 $96
Oxycodone Hcl Generic 17 $94
Meloxicam Generic 38 $68
Tramadol Hcl Generic 16 $50

The 10 drugs with the highest cost, of 11 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 36 billing codes

Paid by Medicare

$54,532

Medicare's payments for the services billed

Medicare patients

89

Average age 72

Services billed

227

51 women, 38 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 45%
Chronic kidney disease 44%
Ischemic heart disease 43%
Depression 34%
Heart failure 26%
COPD 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

467 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record